Please login to the form below

Not currently logged in
Email:
Password:

Creabilis

This page shows the latest Creabilis news and features for those working in and with pharma, biotech and healthcare.

UK biotech gains further £47.2m from Biomedical Catalyst funding

UK biotech gains further £47.2m from Biomedical Catalyst funding

For example, clinical-stage biotech company Creabilis leveraged additional capital alongside its award to fund a large clinical trial in atopic dermatitis.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    175. Creabilis (UK). Sienna. Acquisition. Portfolio of first-in-class topical. 150. Global rights unless stated. ... Deal structure. Comments. Creabilis. Sienna Biopharmaceuticals. $150m. Undisclosed upfront payments. Regulatory and commercial milestone

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics